CRISPR THERAPTC (CRSP) & Cellular Dynamics International (NASDAQ:ICEL) Critical Review – Week Herald
BZ Weekly |
CRISPR THERAPTC (CRSP) & Cellular Dynamics International (NASDAQ:ICEL) Critical Review
Week Herald CRISPR THERAPTC (NASDAQ: CRSP) and Cellular Dynamics International (NASDAQ:ICEL) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, … What's in Crispr Therapeutics AG (NASDAQ:CRSP) After Rise in … CRISPR THERAPTC (NASDAQ:CRSP) Receives $21.92 Average Target Price from Analysts CRISPR THERAPTC (NASDAQ:CRSP) reported earnings of ($0.56) per share beating Walls Streets expectations. |
